65 results on '"Levey, Allan I"'
Search Results
2. Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains
3. Sex differences in brain protein expression and disease
4. Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
5. Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
6. Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Protein Biomarkers in Alzheimer’s Disease
7. Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome
8. CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
9. Shared mechanisms across the major psychiatric and neurodegenerative diseases
10. Cell type-specific biotin labeling in vivo resolves regional neuronal and astrocyte proteomic differences in mouse brain
11. Integrating human brain proteomes with genome-wide association data implicates novel proteins in post-traumatic stress disorder
12. Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
13. Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level
14. Brain microRNAs are associated with variation in cognitive trajectory in advanced age
15. Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue
16. Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer’s disease
17. Brain proteome-wide association study implicates novel proteins in depression pathogenesis
18. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis
19. Feedforward prediction error signals during episodic memory retrieval
20. Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease
21. Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
22. Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease
23. Publisher Correction: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain
24. Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease
25. Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain
26. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease
27. Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation
28. Brain microRNAs associated with late-life depressive symptoms are also associated with cognitive trajectory and dementia
29. Microengineered human blood–brain barrier platform for understanding nanoparticle transport mechanisms
30. Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
31. Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease
32. The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease
33. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins
34. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease
35. Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease
36. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease
37. LSD1 protects against hippocampal and cortical neurodegeneration
38. A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation
39. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease
40. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease
41. TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
42. Proteomics of protein post-translational modifications implicated in neurodegeneration
43. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
44. U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer’s disease due to autosomal dominant genetic mutations and trisomy 21
45. Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease
46. Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
47. Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling
48. Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration
49. 5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging
50. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.